Mariana C. Stern, Ph.D., still remembers the patient from East Los Angeles—Black, uninsured, diagnosed with late-stage lung cancer at 52. Her story, one of ten woven through the AACR’s 2026 Cancer Disparities Progress Report, mirrors a national shift: decades of relentless research have turned the tide for millions, yet the benefits haven’t reached everyone equally. Since 1991, the U.S. has seen a 35% drop in overall cancer deaths—4.8 million lives saved—but the arc of progress bends unevenly. For too long, Black Americans faced a 34% higher cancer mortality rate than white Americans. Now, that gap has shrunk to just 9%, a testament to better access, earlier detection, and targeted interventions. Most strikingly, lung cancer deaths—once 23% more prevalent among Black individuals—have not only closed the gap but reversed it: by 2024, Black Americans had a 4% lower mortality rate than white Americans, a historic turnaround.
The report doesn’t shy from the disparities that remain. Black and American Indian or Alaska Native (AIAN) populations still bear the heaviest burden of cancer deaths in the country. Rural residents are 27% more likely to die from colorectal cancer than their urban counterparts. Women in persistent-poverty counties face cervical cancer death rates 49% higher than those in wealthier areas. And new threats are emerging: early-onset colorectal cancer is rising across all groups, with the sharpest spike among AIAN youth, while Asian women who’ve never smoked are seeing unexpected increases in lung cancer—signs that biology, environment, and systemic inequity are still entangled in complex ways.
Yet the progress is undeniable. Cervical cancer mortality, once 70% higher among Hispanic women compared to white women in 2000, is now only 10% higher. Stomach cancer death rates among Asian or Pacific Islander (API) populations, though still elevated, have dropped from 150% higher to 81% higher over the same period. These numbers reflect not just medical advances but policy wins, community outreach, and culturally competent care. The report underscores the need for sustained federal investment in cancer disparities research—because innovation alone isn’t enough if it doesn’t reach the people who need it most.
Each statistic represents a person: a survivor, a caregiver, a community fighting for equity. The AACR’s report is both a milestone and a mirror—showing how far we’ve come, and how far we have to go. As Dr. Stern puts it, 'The science is working. Now we must ensure it works for everyone.' With 18.6 million cancer survivors in the U.S. and counting, the path forward is clear: close the gaps, listen to the stories, and let progress be measured not just in data, but in lives.